GeoVax Labs, Inc. (GOVX.OB) Granted Allowance by FDA to Start Phase I Clinical Trials for HIV/AIDS Vaccine
GeoVax Labs Inc.is a technology company that creates, develops and tests innovative HIV/AIDS vaccine. The company today announced that it is now allowed by the US Food and Drug Administration (FDA) to begin a Phase 1 clinical trial for Geovax's therapeutic vaccine, which is intended as a treatment for HIV. The company will begin a non-blinded study in HIV infected individuals who started drug treatment during their first year of infection. The protocol for the clinical trial was conceived in collaboration with the AIDS Research Consortium of Atlanta (ARCA). The Phase 1 trial will carefully monitor safety while evaluating the…